panel discussion

Engineering of cell production

~Listen to the voice of the cell and program it ~.

A panel discussion, "Engineering Cell Manufacturing - Listening to and Programming Cells" (session partner Omron Corporation) will be held within the Society for Hyperdifferentiation Osaka Conference 2022 (Saturday, August 27, 2022).

Hyper Interdisciplinary Conference in Osaka 2022

Cell culture control is unavoidable in situations where cells are increased and used, such as in the manufacture of cellular pharmaceuticals or when cells are used in screening of drug candidates. In order to culture a heterogeneous cell population so that it fits within a fixed standard, it is important to know the state of the cell population and reflect this in the culture conditions. What kind of collaboration among different fields will be important in order to program the culture conditions based on the sensing of cell messages such as cell morphology and metabolites produced by the cells, and to build an optimal system as a whole, rather than each of the cells in isolation? In this session, venture companies and researchers will be invited to discuss the future of cell measurement and culture automation.

We will have a program of discussions among researchers, startups, and large companies from a variety of perspectives, not limited to the themes of this session. For more information,Conference Websitefor more information.

*The event will be held after taking measures against new coronavirus infection on the day of the event.

Engineering Cell Manufacturing - Listening to and Programming Cells

Date: Saturday, August 27, 2022, 15:10-16:00
Location: Knowledge Capital Conference Room Tower C
Details:https://hic.lne.st/conference/osaka2022/

speaker

Mr. Yosuke Ozawa
Co-Founder and CEO, Epistra Corporation

He studied bioinformatics at Keio University and worked as a researcher at IBM Research. He then went to England and single-handedly wrote the core system and 9 fundamental patents for the start-up company Ecrebo, which rapidly grew to a market capitalization of over 10 billion yen. After returning to Japan, he led the development of an information system for the experimental robot "Mahoro" at RBI Corporation, an AIST technology transfer venture, and then founded Epistra. In collaboration with RIKEN, he built an AI for trial-and-error of cell recipes for regenerative medicine (published in eLife magazine). He has published original papers in the fields of mathematical optimization, databases, and computational biology.

Mr. Satoshi Kanie
Associate Professor, Faculty of Engineering, Kinki University

D. in engineering from Nagoya University in 2006, and completed his graduate studies at the Graduate School of Engineering, Nagoya University in 2011. D. (Engineering) from the Graduate School of Engineering, Nagoya University in 2011. He was a specially-appointed researcher at the Graduate School of Engineering, Osaka University (2011-2012) and an assistant professor at the Graduate School of Drug Discovery Science, Nagoya University (2012-2022) before assuming his current position from April 2022. His academic affiliations include the Japanese Society for Biotechnology, the Japanese Society for Chemical Engineering, the Japanese Society for Regenerative Medicine, the Japanese Society for Biomaterials, the Japanese Society for Animal Cell Technology, and the Laboratory Automation Research Society. He has been conducting research on cell culture measurement for automation of animal cell culture and biomaterials development using peptides. Currently, he is running his laboratory independently and struggling daily! He realizes the need for manpower (robotics and automation).

Mr. Atsuhiko Negishi
Chief, Industry Marketing Department, Planning Office, Industrial Automation Business Company, OMRON Corporation

Joined OMRON in 2010. As an engineer, he was engaged in the development of temperature control controllers for industrial use and the development of design technology that can withstand adverse environments. After that, he was in charge of planning manufacturing solutions for industries such as image sensors, the automotive industry, the electronics industry, and the food manufacturing industry, and is currently taking on the challenge of launching a new business for the medical field from April 2021!

[Moderator].
Hiroyuki Takahashi
Executive Officer, LIVERNESS Co.

D. from Yokohama City University in 2009. D. in Science, focusing on creating new research projects between industry and young researchers, including the launch of the "Liberace Research Fund" for young researchers under the age of 40. He has been leading the "Association of Hyperdifferent Fields" for many years since its inception, and has also been involved in the creation of places to generate research, such as the establishment of life science laboratories.

Hyper Interdisciplinary Conference in Osaka 2022